Sri Sai Subramanyam Challa. EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES. J Popl Ther Clin Pharmacol 2021, 28 (2), 436-448. https://doi.org/10.53555/jptcp.v28i2.7421.